Hepatitis B Treatment: Medicines, Monitoring, and Long-Term Care

Hepatitis B treatment is not the same for everyone. Some people have a short-term infection that clears without antiviral medicine. Others develop chronic hepatitis B and need regular monitoring, long-term antiviral treatment, or both.

A positive hepatitis B test does not automatically mean that treatment must start immediately. The decision depends on the type and phase of infection, the amount of virus in the blood, liver-enzyme results, liver fibrosis, cirrhosis, age, pregnancy, other infections, immune-suppressing treatment, and additional health risks.

Modern antiviral medicines can suppress hepatitis B virus, reduce liver inflammation, slow or prevent cirrhosis, lower the risk of liver cancer, and improve long-term survival. However, current standard medicines usually control the infection rather than eliminate the virus from every liver cell.

This guide explains acute and chronic hepatitis B, the main medicines, blood tests, treatment monitoring, pregnancy care, family protection, liver-cancer surveillance, daily care, and important questions to ask your healthcare professional.

What Is Hepatitis B?

Hepatitis B is a liver infection caused by the hepatitis B virus, commonly shortened to HBV. The infection may be acute, meaning short term, or chronic, meaning long term.

HBV spreads when infected blood, semen, or certain other body fluids enter another person’s body. Transmission may occur:

• During pregnancy or childbirth
• Through sexual contact
• By sharing needles, syringes, or injecting equipment
• Through an accidental needlestick or occupational blood exposure
• By sharing razors, toothbrushes, or other items that may contain blood
• Through tattooing or piercing with nonsterile equipment
• Through unsafe medical injections or poorly sterilized equipment
• Through direct contact with infected blood or open sores

How Hepatitis B Does Not Usually Spread

Hepatitis B is not normally spread through:

• Hugging
• Holding hands
• Coughing or sneezing
• Sharing ordinary meals
• Sharing forks, spoons, cups, or plates
• Sitting beside someone
• Casual workplace or household contact

People with hepatitis B should not be isolated from normal family, social, school, or workplace activities.

Acute Hepatitis B Versus Chronic Hepatitis B

Acute Hepatitis B

Acute hepatitis B begins after a recent exposure to HBV. Many people have few or no symptoms. When symptoms occur, they may include fatigue, reduced appetite, nausea, vomiting, abdominal discomfort, dark urine, pale stools, joint pain, fever, or jaundice.

There is no routine antiviral treatment for mild acute hepatitis B. Care usually focuses on monitoring and managing symptoms while the immune system responds to the infection.

Severe acute hepatitis, impaired blood clotting, marked jaundice, confusion, or signs of acute liver failure require urgent specialist care. Hospital treatment or liver-transplant assessment may be needed in rare severe cases.

Chronic Hepatitis B

Chronic hepatitis B can remain silent for many years. A person may feel completely well while inflammation or liver fibrosis develops.

The infection can move through different phases. Viral activity, liver-enzyme results, and treatment needs may change over time. This is why one normal blood test does not necessarily end the need for follow-up.

What Are the Goals of Hepatitis B Treatment?

The main treatment goal is to suppress HBV and protect the liver over the long term.

Successful treatment may:

• Lower HBV DNA in the blood
• Reduce liver inflammation
• Normalize or improve liver-enzyme results
• Slow or prevent liver fibrosis
• Reduce the risk of cirrhosis
• Reduce the risk of liver failure
• Lower, but not completely eliminate, the risk of liver cancer
• Improve long-term survival
• Reduce the risk of transmission during pregnancy and birth
• Prevent HBV reactivation in high-risk medical situations

Antiviral treatment does not remove the need for follow-up. Even when HBV DNA becomes undetectable, medicine adherence, liver health, and cancer risk may still need monitoring.

Can Hepatitis B Be Cured?

Current hepatitis B treatment usually controls the virus rather than completely eliminating it from every infected liver cell.

Viral Suppression

Oral antiviral medicine can reduce HBV DNA to very low or undetectable levels. This is called viral suppression. It substantially lowers the chance of ongoing liver injury but is not the same as complete eradication of the virus.

Functional Cure

A functional cure generally refers to sustained loss of hepatitis B surface antigen, or HBsAg, with continued control of the virus after treatment. This can occur, but it remains uncommon with current standard oral antiviral treatment.

Why the Virus Can Persist

HBV can leave a stable form of viral genetic material inside liver cells. This makes complete elimination difficult, even when blood tests show excellent viral suppression.

Researchers are studying new combinations designed to achieve functional cure more often. Until such treatments are proven and approved, readers should be cautious of products that promise a fast, natural, or guaranteed hepatitis B cure.

Who May Need Chronic Hepatitis B Treatment?

Treatment eligibility is based on the complete clinical picture rather than one test result.

Factors may include:

• HBV DNA level
• ALT and other liver-enzyme results
• Evidence of significant fibrosis
• Cirrhosis
• Age
• HBeAg status
• Family history of cirrhosis or liver cancer
• Other causes of liver injury
• Pregnancy and the risk of transmission to the baby
• Hepatitis D, hepatitis C, or HIV coinfection
• Planned chemotherapy or immune-suppressing treatment
• Organ or bone-marrow transplantation
• Personal preferences and ability to continue monitoring

People With Cirrhosis

People with cirrhosis generally require specialist management. Antiviral treatment may be indicated even when HBV DNA is not extremely high because preventing further liver injury is especially important.

People in an Indeterminate Phase

Some people do not fit neatly into a clearly active or inactive phase. Updated guidance gives greater attention to age, fibrosis, ALT, viral load, family history, and other risk factors when deciding whether treatment or closer monitoring is appropriate.

People Not Starting Medicine Yet

Not needing medicine today does not mean the infection has disappeared. A monitoring plan may still include repeat HBV DNA, liver enzymes, fibrosis assessment, and liver-cancer surveillance when indicated.

Tests Before Starting Hepatitis B Treatment

A clinician may use blood tests, imaging, and fibrosis assessment to understand the infection and select an appropriate care plan.

Hepatitis B Blood Tests

• HBsAg: Indicates current hepatitis B infection when confirmed positive
• Anti-HBs: May indicate immunity after vaccination or recovery
• Total anti-HBc: Indicates previous or current exposure to HBV
• IgM anti-HBc: May help identify a recent acute infection
• HBeAg and anti-HBe: May help describe the phase of infection
• HBV DNA: Measures the amount of viral genetic material in the blood

Liver and General Health Tests

• ALT and AST
• Bilirubin
• Albumin
• Platelet count
• INR or another blood-clotting test
• Complete blood count
• Kidney-function tests
• Blood sugar and metabolic-health tests when relevant

Testing for Other Infections

Testing may also include:

• Hepatitis D
• Hepatitis C
• HIV
• Hepatitis A immunity

Hepatitis D requires hepatitis B to infect a person and can lead to more aggressive liver disease. Testing decisions depend on risk, local guidance, and clinical circumstances.

Assessing Liver Fibrosis

Possible methods include:

• Transient elastography, often known by the brand name FibroScan
• Ultrasound
• Blood-based fibrosis scores
• Other liver-stiffness imaging
• Liver biopsy in selected cases

Not every person needs every test. The clinician selects tests based on the individual situation.

For general education about tests and screening limitations, visit the NextFitLife Medical Tests and Screenings Hub.

Main Medicines for Chronic Hepatitis B

The main oral medicines are nucleoside or nucleotide analogues. They block viral replication and can suppress HBV DNA effectively.

Tenofovir Disoproxil Fumarate

Tenofovir disoproxil fumarate is commonly shortened to TDF. It has strong antiviral activity and a high barrier to resistance.

A clinician may monitor:

• Kidney function
• Phosphate or other laboratory results when relevant
• Bone health in people with risk factors
• HBV DNA and liver enzymes

TDF has extensive experience in hepatitis B treatment, including use in appropriately selected pregnant patients when antiviral prophylaxis is needed.

Tenofovir Alafenamide

Tenofovir alafenamide is commonly shortened to TAF. It delivers tenofovir to cells at a lower circulating dose than TDF.

TAF may be considered when kidney or bone health is an important part of medicine selection. However, it is not automatically the right choice for every patient.

Availability, pregnancy, other medicines, HIV status, kidney function, cirrhosis, and local guidelines may affect its use.

Entecavir

Entecavir is a potent oral antiviral medicine with a high resistance barrier in patients who have not previously developed resistance to certain older HBV medicines.

Medical history matters because previous lamivudine exposure or resistance may affect whether entecavir is the best option.

People with unrecognized or untreated HIV need careful evaluation before entecavir is used because HBV and HIV treatment must be coordinated correctly.

Pegylated Interferon

Pegylated interferon is an injectable immune-modulating treatment used for selected patients. Unlike oral antiviral treatment, it is given for a defined course rather than automatically continuing indefinitely.

It may offer a higher chance of certain off-treatment responses in carefully selected people, but it has more contraindications and side effects than oral antivirals.

Possible concerns include:

• Flu-like symptoms
• Fatigue
• Mood or psychiatric effects
• Low blood-cell counts
• Thyroid changes
• Autoimmune complications
• Pregnancy risk

It is unsuitable for many people, including some patients with decompensated cirrhosis, pregnancy, uncontrolled psychiatric illness, or certain autoimmune conditions.

Older Hepatitis B Medicines

Older medicines include lamivudine, adefovir, and telbivudine. They are used less frequently as first-choice treatment because newer options generally provide stronger viral suppression, a better resistance profile, or other clinical advantages.

Do not change from an older medicine without specialist advice. An apparently simple switch may need resistance history, kidney tests, HIV testing, and a carefully planned transition.

Hepatitis B Medicine Comparison

This table provides general education. It cannot be used to select a medicine or dose.

How Long Does Hepatitis B Treatment Last?

Treatment duration depends on the medicine, HBeAg status, cirrhosis, treatment response, HBsAg status, and the safety of stopping.

Oral Antiviral Treatment

Many people who start oral antiviral therapy remain on it for years. Some need lifelong treatment.

Stopping treatment may be considered only in carefully selected patients who meet guideline-based criteria and can complete close follow-up. Even then, viral relapse and hepatitis flares can occur.

Pegylated Interferon

Pegylated interferon is normally prescribed as a time-limited course. The person still needs follow-up after the course ends to determine whether the response is sustained.

Why Stopping Medicine Can Be Dangerous

After oral medicine is stopped, HBV DNA may rise quickly. This can lead to:

• Increased ALT
• Renewed liver inflammation
• Jaundice
• Loss of liver function
• Rarely, liver failure

Never stop treatment because a viral-load result is undetectable or because you feel well. Ask the prescribing clinician before making any change.

Monitoring During Hepatitis B Treatment

Treatment involves more than taking a tablet. Monitoring confirms whether the medicine is working and whether the liver and other organs remain safe.

The plan may include:

• HBV DNA
• ALT and AST
• Bilirubin
• Albumin
• Platelet count
• INR when relevant
• HBeAg and anti-HBe when relevant
• HBsAg
• Kidney function
• Bone-health assessment when appropriate
• Fibrosis assessment
• Medicine adherence review
• Medicine-interaction and side-effect review
• Liver-cancer surveillance when indicated

What If HBV DNA Does Not Fall as Expected?

The clinician may investigate:

• Missed doses
• Incorrect medicine use
• Medicine interactions
• Reduced absorption
• Previous antiviral resistance
• Incorrect diagnosis or disease classification
• Hepatitis D, hepatitis C, or HIV coinfection
• Other causes of liver inflammation

Tell your clinician honestly about missed doses. This information helps the care team solve the problem safely.

Monitoring When Medicine Is Not Started

A person who does not currently meet treatment criteria may still need periodic:

• ALT testing
• HBV DNA measurement
• HBeAg or HBsAg assessment
• Fibrosis review
• Liver imaging
• Liver-cancer surveillance when indicated

The interval depends on the phase of infection, age, results, family history, and other risks.

Liver-Cancer Surveillance With Chronic Hepatitis B

Chronic hepatitis B can increase the risk of hepatocellular carcinoma, the most common primary liver cancer.

Antiviral treatment lowers this risk but does not eliminate it completely.

People who meet surveillance criteria are often monitored approximately every six months with liver ultrasound, sometimes together with an alpha-fetoprotein blood test. CT or MRI may be used when ultrasound is inadequate or a concerning finding needs further evaluation.

Surveillance decisions may consider:

• Cirrhosis
• Age
• Sex
• Country or region of birth
• Family history of liver cancer
• Hepatitis D coinfection
• Other clinical risk scores or factors

Ask your clinician whether you need liver-cancer surveillance and exactly how often it should occur.

Hepatitis B Treatment During Pregnancy

Hepatitis B during pregnancy requires coordinated care because HBV can pass to the baby during childbirth.

Screening During Every Pregnancy

Pregnant patients should be screened for HBsAg during each pregnancy, preferably early, even if they were vaccinated, tested previously, or known to have chronic hepatitis B.

HBV DNA Testing

A pregnant patient with confirmed HBsAg positivity should have HBV DNA measured. The result helps determine whether maternal antiviral prophylaxis is recommended to reduce transmission.

Antiviral Prophylaxis

Many guidelines recommend maternal antiviral treatment when HBV DNA is very high, commonly around 200,000 IU/mL or greater. TDF has extensive evidence and is commonly used when prophylaxis is indicated.

The exact starting and stopping plan must be determined by the obstetric and liver or infectious-disease care team. Monitoring after delivery is important because hepatitis flares can occur.

Protection for the Baby

An infant born to an HBsAg-positive parent should receive:

• Hepatitis B vaccine within 12 hours after birth
• Hepatitis B immune globulin, or HBIG, within 12 hours after birth
• The remaining vaccine-series doses on schedule
• Post-vaccination blood testing at the recommended age

Post-vaccination serologic testing generally includes HBsAg and anti-HBs at 9 to 12 months of age, or one to two months after completing a delayed vaccine series.

Breastfeeding

Breastfeeding is generally considered safe when the infant receives appropriate birth prophylaxis. A clinician may recommend temporarily avoiding feeding from a breast with cracked or bleeding nipples because blood exposure may increase risk.

How to Protect Partners and Family Members

Household members, sexual partners, and needle-sharing contacts should ask about hepatitis B testing and vaccination.

CDC testing often uses a triple panel:

• HBsAg
• Anti-HBs
• Total anti-HBc

This can help determine whether a person is currently infected, previously exposed, immune through vaccination, or still susceptible.

Practical Protection Steps

• Do not share razors, toothbrushes, nail clippers, or glucose-testing equipment
• Cover open cuts and sores
• Clean blood spills safely
• Do not share needles or injecting equipment
• Use condoms until a sexual partner’s immunity is confirmed
• Choose sterile tattoo and piercing services
• Tell medical and dental professionals that you have hepatitis B
• Do not donate blood, semen, organs, or tissue unless a specialist program specifically advises otherwise

Testing and vaccination should not be delayed because of shame or fear. Hepatitis B is a medical infection, and vaccination provides highly effective prevention.

Explore the Infections and Immune Health Hub for more general infection-prevention education.

Hepatitis B With Hepatitis D, Hepatitis C, or HIV

Hepatitis D

Hepatitis D virus can infect only someone who also has hepatitis B. It may accelerate fibrosis and raise the risk of cirrhosis or liver complications.

People with hepatitis B should ask whether hepatitis D testing is appropriate, especially when they come from an area where HDV is more common, have unexplained liver inflammation, or have other exposure risks.

Hepatitis C

A person can have HBV and hepatitis C together. Treatment of hepatitis C can sometimes trigger HBV reactivation, so HBV status must be reviewed before and during hepatitis C treatment.

HIV

HBV and HIV treatment must be coordinated. Some antiretroviral medicines treat both viruses, while poorly planned treatment can lead to resistance or HBV flare.

Do not start or stop HIV medicines without specialist guidance when hepatitis B is also present.

Hepatitis B Reactivation During Immune-Suppressing Treatment

HBV can reactivate in someone with current or previous hepatitis B when the immune system is suppressed.

Higher-risk situations may include:

• Certain chemotherapy medicines
• B-cell-depleting treatments
• Stem-cell or organ transplantation
• Prolonged or high-dose corticosteroid treatment
• Some biological medicines for autoimmune disease
• Other strong immune-suppressing therapies

Before chemotherapy or immune-suppressing treatment, clinicians may test HBsAg, anti-HBc, and anti-HBs. Some people need preventive antiviral medicine before immune suppression begins.

Tell every specialist about current or previous hepatitis B, even if you were told years ago that the infection had cleared.

Daily Care With Chronic Hepatitis B

Daily habits cannot replace antiviral medicine or monitoring, but they can help reduce additional liver stress and support general health.

Avoid or Limit Alcohol as Advised

Alcohol can add further liver injury. Many people with chronic liver disease are advised to avoid it completely.

Ask the clinician who knows your liver status whether any alcohol is considered safe. A person who drinks heavily or may be physically dependent should seek medical advice before stopping suddenly because withdrawal can be dangerous.

Eat a Balanced Diet

There is no special food that removes hepatitis B. A balanced pattern may include:

• Vegetables
• Whole fruit
• Beans and lentils
• Whole grains when suitable
• Fish
• Eggs, poultry, tofu, or other suitable protein foods
• Nuts and seeds in appropriate portions
• Unsaturated fats such as olive oil

Maintaining an appropriate weight may be important because metabolic fatty liver disease can add to liver injury in a person who already has hepatitis B.

For general food guidance, read foods that may fit a liver-supportive eating pattern and visit the Kidney and Liver Health Foods Hub.

Use Medicines and Supplements Safely

Tell your care team about every:

• Prescription medicine
• Over-the-counter medicine
• Vitamin
• Herbal product
• Detox tea
• Bodybuilding supplement
• Weight-loss product
• Traditional remedy

Do not assume that a “liver cleanse” protects the liver. Some supplements can interact with antiviral medicine or cause liver injury.

Read Liver Detox: 10 Safer Ways to Support Liver Health for a cautious explanation of cleanse and supplement claims.

Stay Physically Active When Safe

Regular movement can support cardiovascular health, blood sugar, weight management, mood, and physical function.

Ask for individualized guidance if you have cirrhosis, abdominal swelling, severe fatigue, muscle loss, breathing problems, balance concerns, or another condition that affects exercise safety.

Get Recommended Vaccinations

Ask whether you need hepatitis A vaccination and whether other routine vaccines are up to date. Hepatitis A infection can cause additional liver stress in someone with chronic hepatitis B.

What Should You Avoid With Hepatitis B?

• Do not stop antiviral medicine without medical advice
• Do not skip monitoring because you feel well
• Do not rely on detox drinks, herbs, or juice cleanses to treat HBV
• Do not share needles, razors, toothbrushes, or blood-contaminated items
• Do not hide the diagnosis from clinicians prescribing immune-suppressing medicine
• Do not take multiple supplements without checking for safety
• Do not assume a normal ALT result means follow-up is unnecessary
• Do not donate blood
• Do not ignore jaundice, bleeding, confusion, or abdominal swelling

What If Hepatitis B Treatment Is Not Working?

A detectable or rising viral load does not always mean the medicine itself has failed.

The clinician may review:

• Whether every dose is being taken
• Timing and method of medicine use
• Pharmacy access and affordability
• Medicine interactions
• Previous treatment history
• Possible antiviral resistance
• Kidney function or dose adjustment
• Coinfections
• Other causes of abnormal liver enzymes

Do not double a missed dose unless the medicine instructions or pharmacist specifically advise it. Ask the prescribing team how to handle missed doses.

Current Hepatitis B Research

Researchers are studying ways to increase the chance of functional cure. Investigational approaches include:

• RNA-targeting treatments
• Capsid assembly modulators
• Entry inhibitors
• Therapeutic vaccines
• Immune-modulating medicines
• Agents targeting HBsAg production
• Combination-treatment strategies

These approaches are promising research areas, but many remain experimental. Do not buy an unapproved product or join an unregulated treatment program because it claims to cure hepatitis B.

A regulated clinical trial should include informed consent, qualified investigators, safety monitoring, and independent oversight.

Warning Signs and When to Seek Care

Arrange Medical Assessment for:

• New or worsening fatigue
• Reduced appetite
• Nausea or vomiting
• Dark urine
• Pale stools
• Itchy skin
• Yellow skin or eyes
• Persistent upper-right abdominal discomfort
• Swollen ankles or legs
• Unexplained weight loss
• Increasing abdominal size
• New medicine side effects

Seek Urgent Medical Help for:

• Vomiting blood
• Black, tar-like stools
• Severe confusion
• Unusual sleepiness or inability to stay awake
• Fainting
• Rapidly increasing abdominal swelling
• Severe abdominal pain
• Difficulty breathing
• Severe weakness
• Jaundice with fever or rapidly worsening illness

Simple 7-Day Hepatitis B Care Organization Plan

This plan does not replace medical treatment. It can help a person prepare for better care.

Daily Hepatitis B Checklist

• Did I take my medicine exactly as prescribed?
• Did I avoid sharing personal items that may contain blood?
• Did I avoid unverified detox or liver-cleanse products?
• Did I record any new symptoms or side effects?
• Did I follow my clinician’s alcohol guidance?
• Did I keep my testing and appointment schedule?
• Did I tell new healthcare professionals about hepatitis B?
• Did I avoid stopping or changing medicine myself?

Questions to Ask Your Healthcare Professional

• Do I have acute or chronic hepatitis B?
• Which phase of chronic hepatitis B am I in?
• What do my HBsAg, anti-HBs, anti-HBc, HBeAg, and HBV DNA results mean?
• Is there evidence of liver fibrosis or cirrhosis?
• Do I need antiviral treatment now?
• Why is this medicine preferred for me?
• How should I take it?
• What interactions or side effects should I watch for?
• How often should HBV DNA and liver enzymes be checked?
• Do I need kidney or bone monitoring?
• Do I need hepatitis D, hepatitis C, or HIV testing?
• Do I need liver-cancer surveillance?
• Should I avoid alcohol completely?
• Which family members or partners need testing or vaccination?
• What should I do if I miss a dose?
• Under what circumstances could treatment ever be stopped safely?

Key Takeaway

Hepatitis B treatment depends on the phase of infection, viral activity, liver health, pregnancy, other infections, and additional risk factors.

Acute hepatitis B usually receives supportive care. Chronic hepatitis B may require long-term monitoring, antiviral medicine, or both.

TDF, TAF, and entecavir are common preferred oral treatments. Pegylated interferon may be considered for selected patients. These medicines can suppress the virus, protect the liver, and reduce major complications, but they do not usually provide a complete cure.

Do not stop antiviral treatment on your own. Keep monitoring appointments, ask whether liver-cancer surveillance is needed, and help partners and family members obtain testing and vaccination.

Recommended next step: Prepare your laboratory results and medicine list, then ask your healthcare professional which monitoring and treatment plan applies to your specific infection.

References and Sources

1. 
   World Health Organization: Guidelines for the Prevention, Diagnosis, Care and Treatment for People With Chronic Hepatitis B Infection
   
2. 
   World Health Organization: Hepatitis B Fact Sheet
   
3. 
   American Association for the Study of Liver Diseases: 2025 Practice Guideline on Treatment of Chronic Hepatitis B
   
4. 
   American Association for the Study of Liver Diseases: Hepatitis B Practice Guidelines
   
5. 
   Centers for Disease Control and Prevention: Hepatitis B Basics
   
6. 
   Centers for Disease Control and Prevention: Clinical Testing and Diagnosis for Hepatitis B
   
7. 
   Centers for Disease Control and Prevention: Clinical Overview of Perinatal Hepatitis B
   
8. 
   Centers for Disease Control and Prevention: Perinatal Hepatitis B Testing Guidance
   
9. 
   National Institute of Diabetes and Digestive and Kidney Diseases: Hepatitis B
   

Related NextFitLife Guides and Hub Links

Related Liver and Health Guides

• Liver Detox: 10 Safer Ways to Support Liver Health
• Foods Good for Liver: Food and Meal Ideas
• Kidney and Liver Health Foods Hub
• How to Differentiate Gallbladder and Liver Pain
• Secondary Liver Cancer: Symptoms, Diagnosis, and Care Questions

NextFitLife Topic Hubs

• Infections and Immune Health Hub
• Medical Tests and Screenings Hub
• Digestive Health and Gut Hub
• Foods and Nutrition Hub
• Health Hub

About the Author

Adel Galal is the founder and lead writer of NextFitLife. He has more than 15 years of health and wellness writing experience and more than 30 years of personal study and practical interest in nutrition, fitness, sleep, healthy aging, and preventive wellness.

For this guide, Adel reviewed current information from the World Health Organization, the Centers for Disease Control and Prevention, the American Association for the Study of Liver Diseases, and the National Institute of Diabetes and Digestive and Kidney Diseases. His role is to compare authoritative sources, identify misleading cure or detox claims, and explain complex information in accessible language.

Adel is not a physician, hepatologist, infectious-disease specialist, pharmacist, obstetrician, registered dietitian, or licensed healthcare professional. This article provides general education and cannot diagnose hepatitis B, interpret personal laboratory results, determine eligibility for antiviral treatment, select a medicine, or replace individualized medical care.

Learn more about the author, research process, qualifications, medical-review limitations, and editorial policies on the NextFitLife About page.

Frequently Asked Questions About Hepatitis B Treatment

What is the treatment for hepatitis B?

Acute hepatitis B usually receives supportive medical care and monitoring. Chronic hepatitis B may require antiviral medicine, regular blood tests, fibrosis assessment, and liver-cancer surveillance. Treatment depends on viral activity, liver damage, pregnancy, coinfections, and other risk factors.

Does everyone with chronic hepatitis B need medicine?

No. Some people need antiviral medicine, while others need regular monitoring without immediate treatment. The decision is based on HBV DNA, liver enzymes, fibrosis, cirrhosis, age, family history, pregnancy, coinfections, and other clinical factors.

Which medicines are used for chronic hepatitis B?

Common preferred oral medicines include tenofovir disoproxil fumarate, tenofovir alafenamide, and entecavir. Pegylated interferon may be considered for selected patients but has more side effects and contraindications.

Can hepatitis B be cured completely?

Current standard treatment can suppress hepatitis B and greatly reduce the risk of liver complications. It does not usually remove every trace of the virus from liver cells. Functional cure, involving sustained HBsAg loss, can occur but remains uncommon.

How long does hepatitis B treatment last?

Many people take oral antiviral medicine for years, and some require lifelong treatment. Treatment should be stopped only when strict medical criteria are met and close follow-up is available.

What tests are needed during hepatitis B treatment?

Monitoring may include HBV DNA, ALT, AST, bilirubin, albumin, platelets, HBsAg, HBeAg, kidney function, fibrosis assessment, medicine side-effect checks, and liver-cancer surveillance when indicated.

Is it dangerous to stop hepatitis B medicine?

Stopping antiviral medicine can allow HBV DNA to rise and may trigger a hepatitis flare. Severe flares can cause jaundice, loss of liver function, or rarely liver failure. Never stop treatment without guidance from the prescribing clinician.

How is hepatitis B managed during pregnancy?

Pregnant patients should be screened during each pregnancy. Those who are HBsAg-positive should have HBV DNA measured. Antiviral prophylaxis may be recommended when viral load is high. The baby should receive hepatitis B vaccine and HBIG within 12 hours after birth.

How can family members and partners be protected?

Household members, sexual partners, and needle-sharing contacts should ask about hepatitis B testing and vaccination. Avoid sharing needles, razors, toothbrushes, nail clippers, or equipment that may contain blood.

Who needs liver-cancer surveillance?

Surveillance may be recommended for people with cirrhosis and selected higher-risk groups with chronic hepatitis B. It is often performed about every six months with liver ultrasound, sometimes with an AFP blood test.

Can detox drinks or supplements treat hepatitis B?

No. Detox drinks, juice cleanses, teas, and supplements cannot eliminate HBV. Some supplements may interact with medicine or injure the liver. Hepatitis B care requires appropriate testing, monitoring, prevention, and antiviral treatment when indicated.

When should someone with hepatitis B seek urgent care?

Seek urgent care for vomiting blood, black stools, severe confusion, fainting, rapidly increasing abdominal swelling, difficulty breathing, severe abdominal pain, unusual sleepiness, severe weakness, or jaundice with rapidly worsening illness.

Medical Disclaimer

All health content on NextFitLife is provided for general educational and informational purposes only. It is not intended to replace professional medical advice, diagnosis, testing, treatment, public-health guidance, pregnancy care, or emergency care.

Always consult a qualified healthcare professional before starting, changing, missing, or stopping antiviral medicine; changing alcohol intake; using supplements; planning pregnancy; breastfeeding with bleeding nipples; receiving chemotherapy or immune-suppressing treatment; or changing a monitoring or vaccination plan.

Seek urgent medical help for vomiting blood, black stools, severe confusion, fainting, rapidly increasing abdominal swelling, difficulty breathing, severe abdominal pain, unusual sleepiness, severe weakness, jaundice with rapidly worsening illness, or another medical emergency.